Management of Nephrotic Syndrome
The management of nephrotic syndrome requires a comprehensive therapeutic approach focused on maintaining intravascular euvolemia, adequate nutrition, preventing complications, and preserving kidney function while addressing the underlying cause when possible. 1
Initial Assessment and Diagnosis
- Nephrotic syndrome is characterized by nephrotic-range proteinuria, hypoalbuminemia, edema, and often hyperlipidemia 2
- In children, minimal change disease and focal segmental glomerulosclerosis (FSGS) are most common causes 2, 3
- In adults, FSGS and membranous nephropathy are the most common primary causes, with diabetes being the most common secondary cause 2, 4
- Genetic testing and kidney biopsy are warranted in steroid-resistant cases to determine the specific diagnosis 2, 3
Core Management Strategies
Fluid and Sodium Management
- Restrict dietary sodium to control edema 4
- Administer diuretics (primarily furosemide 0.5-2 mg/kg per dose up to six times daily) for patients with intravascular fluid overload and preserved kidney function 1
- Consider administering furosemide (0.5-2 mg/kg) at the end of albumin infusions unless the patient has marked hypovolemia or hyponatremia 1
- Avoid diuretics in patients with evidence of intravascular hypovolemia 1
Proteinuria Reduction
- For children with idiopathic nephrotic syndrome, glucocorticoids are the cornerstone of treatment 2, 3
- In adults, angiotensin-converting enzyme inhibitors are recommended to reduce proteinuria 4
- Prednisone is indicated to induce diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus 5
Prevention and Management of Complications
Thromboembolism Prophylaxis
- Consider anticoagulation prophylaxis for patients at high risk of thromboembolism, particularly those with membranous nephropathy 2
- Monitor for signs of venous thromboembolism, which is a common complication 4
Infection Prevention
- Implement infection prophylaxis measures, especially in children with congenital nephrotic syndrome 1
- Monitor closely for signs of infection, as patients are at increased risk due to urinary loss of immunoglobulins 6
Hyperlipidemia Management
- Address hyperlipidemia, which is a common feature of nephrotic syndrome 6, 7
- Consider lipid-lowering therapy in persistent cases 7
Nutritional Support
- Ensure adequate nutrition to prevent malnutrition and support growth, particularly in children 1, 3
- Consider growth hormone substitution in children with growth impairment 1
Special Considerations for Congenital Nephrotic Syndrome
- Manage with a multidisciplinary team including specialized pediatric nephrology 1
- Ambulatory management is recommended when possible to improve quality of life and reduce risk of nosocomial infections 1
- Home administration of albumin infusions by trained parents is feasible and safe 1
- Nephrectomy is not routinely recommended but should be considered in patients with severe complications despite optimal conservative treatment 1
- Consider nephrectomy before transplantation in patients with persisting nephrotic syndrome and/or WT1-dominant pathogenic variant 1
Treatment Based on Response Pattern
Steroid-Sensitive Nephrotic Syndrome
- Initial and infrequent recurrences can be managed with glucocorticoids 3
- For frequent relapses or steroid dependence, consider steroid-sparing agents such as levamisole, mycophenolate mofetil, calcineurin inhibitors, anti-CD20 monoclonal antibodies, or cyclophosphamide 3
Steroid-Resistant Nephrotic Syndrome
- Consider calcineurin inhibitors as second-line therapy 3
- For multidrug-resistant cases, prepare for potential progression to kidney failure 3
- Genetic testing is important as up to one-third of steroid-resistant cases have a monogenic origin 3
Monitoring and Follow-up
- Regularly monitor blood pressure, fluid status, proteinuria, and kidney function 2, 3
- In children, monitor growth velocity as it may be affected by corticosteroid treatment 5
- Watch for medication side effects, particularly with long-term steroid use 3
Pitfalls and Caveats
- Avoid routine early nephrectomies in congenital nephrotic syndrome 1
- Do not use immunosuppressive agents for genetic forms of congenital nephrotic syndrome as they are unlikely to respond 1
- Be cautious with diuretic dosing; doses >6 mg/kg per day should not be given for periods longer than 1 week 1
- In pediatric patients, recognize that growth velocity may be a more sensitive indicator of systemic corticosteroid exposure than laboratory tests of HPA axis function 5
- Consider the increased risk of diabetes mellitus, fluid retention, and hypertension in elderly patients treated with corticosteroids 5